Peyton Greenside

Peyton Greenside is CEO and co-founder of BigHat Biosciences, where she leads the development of AI- and synthetic-biology-enabled platforms for designing next-generation antibody therapeutics. She is a computational biologist and former Schmidt Science Fellow, with research and industry experience spanning biological sequence modeling, machine learning, and protein engineering.

Career